Albireo reports inducement grant under nasdaq listing rule 5635(c)(4)
Boston, dec. 20, 2022 (globe newswire) -- albireo pharma, inc. (nasdaq: albo), a rare liver disease company developing novel bile acid modulators to treat pediatric and adult liver diseases, today announced the grant to its newly appointed chief medical officer, paul d. streck, m.d., of inducement restricted stock units to acquire 63,966 shares of albireo's common stock. the restricted stock units were granted as an inducement material to dr. streck's acceptance of employment with albireo in accordance with nasdaq listing rule 5635(c)(4). the restricted stock units vest over a four-year period, subject to the employee's continued service with albireo through the applicable vesting dates. the vesting schedule for each restricted stock unit is 25 percent on the one-year anniversary of the employee's start date with albireo and 75 percent in 12 equal quarterly installments thereafter. the restricted stock units are subject to the terms and conditions of albireo's 2020 inducement equity incentive plan.
ALBO Ratings Summary
ALBO Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission